AMRYT AND SWIXX SIGN DISTRIBUTION DEAL FOR MYALEPTA ACROSS 17 JURISDICTIONS IN CENTRAL AND EASTERN EUROPE (“CEE”)
03 juin 2020 07h00 HE
|
Amryt Pharma Plc
June 3, 2020 AIM: AMYT Euronext Growth: AYP AMRYT PHARMA PLC (“Amryt” or the “Company”) AMRYT AND SWIXX SIGN DISTRIBUTION DEAL FOR MYALEPTA ACROSS 17 JURISDICTIONS IN CENTRAL AND EASTERN EUROPE...
Amryt Pharma Plc - Q1 2020 RESULTS
11 mai 2020 07h00 HE
|
Amryt Pharma Plc
May 11, 2020 AIM: AMYT Euronext Growth: AYP AMRYT PHARMA PLC (“Amryt” or the “Company”) Q1 2020 RESULTS $44.6M unaudited Q1 revenues representing a 30% increase on unaudited combined revenues of...
Amryt Pharma Plc - Full Year 2019 RESULTS
11 mai 2020 07h00 HE
|
Amryt Pharma Plc
May 11, 2020 AIM: AMYT Euronext Growth: AYP AMRYT PHARMA PLC (“Amryt” or the “Company”) FY 2019 RESULTS Transformational year of performance and growth for AmrytAegerion integration...
Filsuvez® Confirmed as Global Brand Name for Ap101
07 mai 2020 07h00 HE
|
Amryt Pharma Plc
7 May 2020 AIM: AMYT Euronext Growth: AYP AMRYT PHARMA PLC (“Amryt” or the “Company”) FILSUVEZ® CONFIRMED AS GLOBAL BRAND NAME FOR AP101 Amryt, a global, commercial-stage biopharmaceutical company...
Notice of Results
07 mai 2020 07h00 HE
|
Amryt Pharma Plc
07 May 2020 AIM: AMYT Euronext Growth: AYP AMRYT PHARMA PLC (“Amryt” or the “Company”) Notice of Results Amryt, a global, commercial-stage biopharmaceutical company dedicated to commercializing and...
Amryt Pharma plc: Lojuxta to be reimbursed in France
17 oct. 2018 07h00 HE
|
Amryt Pharma Plc
17 October 2018AIM: AMYTESM: AYP Amryt Pharma plc(“Amryt” or the “Company”) Lojuxta to be reimbursed in France Amryt’s lead commercial product now available in all five of the EU’s largest markets ...
Amryt receives IND approval from FDA for AP101 enabling the opening of US clinical trial sites
10 sept. 2018 07h00 HE
|
Amryt Pharma Plc
10 September 2018AIM: AMYT ESM: AYP Amryt Pharma plc(“Amryt” or the “Company”) Amryt receives IND approval from FDA for AP101 enabling the opening of US clinical trial sites Amryt, a...
Amryt Pharma plc: NHS England approves funding for Lojuxta
09 juil. 2018 07h00 HE
|
Amryt Pharma Plc
9 July 2018AIM: AMYT Amryt Pharma plc(“Amryt” or the “Company”) NHS England approves funding for Lojuxta Amryt, a biopharmaceutical company focused on rare and orphan diseases, is pleased to...